Ontology highlight
ABSTRACT: Background: Influenza A virus (IAV) causes a wide spectrum of clinical outcomes, from mild symptoms to life-threatening pneumonia. Recent studies have highlighted the role of the upper respiratory tract (URT) microbiota in modulating immune responses and influencing disease severity, yet the underlying mechanisms remain poorly understood. Purpose: To investigate how the URT microbiota and host metabolic profiles differ between mild and severe influenza A cases, and to elucidate potential microbiota–metabolome interactions contributing to disease pathogenesis. Methods: We enrolled 392 adult patients with laboratory-confirmed IAV between October 2022 and December 2023. Pharyngeal swabs and blood samples were collected for microbiome and metabolome profiling. URT microbiota was assessed via 16S ribosomal RNA (16S rRNA) and metagenomic sequencing, while plasma metabolites were profiled using untargeted metabolomics. Results: Among 392 age- and sex-matched patients (196 mild, 196 severe), the severe group exhibited significantly higher white blood cell (WBC), neutrophil (NEU), platelet (PLT), and high-sensitivity C-reactive protein (hs-CRP) levels. Microbiome analysis revealed greater α-diversity (Observed Features, Chao1, ACE) in severe cases, while β-diversity remained comparable. 16S rRNA and metagenomic sequencing showed high concordance at the genus level, with metagenomics providing improved species-level resolution. Linear discriminant analysis effect size (LEfSe) identified enrichment of pathogenic taxa including Parvimonas micra and Veillonella parvula, as well as inflammation-associated pathways in severe cases, whereas mild cases harbored taxa and metabolic functions potentially associated with host defense. Metabolomic profiling revealed 122 differential plasma metabolites; anti-inflammatory and antioxidant metabolites were enriched in mild cases, whereas lipid biosynthesis and glycosylation-related metabolites were significantly enriched in severe cases. Microbial diversity and specific taxa abundances correlated with immune markers, supporting microbiota–host immune interactions in disease severity. Conclusion: This study reveals distinct compositional and functional alterations in the URT microbiota between mild and severe IAV cases. Severe cases are characterized by higher microbial richness and pro-inflammatory microbial functions, whereas mild cases exhibit protective metabolic signatures. These findings underscore the potential of targeting the microbiota–metabolome axis in predicting influenza severity and developing novel host–microbiome-based therapies.
INSTRUMENT(S): Liquid Chromatography MS - positive - HILIC, Liquid Chromatography MS - negative - HILIC
PROVIDER: MTBLS13112 | MetaboLights | 2025-11-03
REPOSITORIES: MetaboLights
Items per page: 1 - 5 of 6 |